Integra LifeSciences Holdings (IART)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,608,880 | 1,486,360 | 1,506,670 | 1,533,950 | 1,298,690 |
| Total assets | US$ in thousands | 4,037,420 | 3,781,990 | 3,889,760 | 3,782,380 | 3,615,140 |
| Total asset turnover | 0.40 | 0.39 | 0.39 | 0.41 | 0.36 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $1,608,880K ÷ $4,037,420K
= 0.40
Integra LifeSciences Holdings has shown a consistent trend in its total asset turnover ratio over the years. The ratio increased from 0.36 in December 2020 to 0.41 in December 2021, indicating that the company generated $0.41 in revenue for every $1 of total assets during that period. Although there was a slight decrease in the ratio to 0.39 in both December 2022 and December 2023, it remained relatively stable. The ratio then improved to 0.40 by December 2024, showing a positive sign of efficiency in utilizing its assets to generate sales. Overall, the company's total asset turnover demonstrates a satisfactory efficiency in generating revenue relative to its total asset base during the analyzed period.
Peer comparison
Dec 31, 2024